UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

Diabetologia, 2001-03, Vol.44 (3), p.305-308

2001

Volltextzugriff (PDF)

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride

Cardiovascular diabetology, 2021-12, Vol.20 (1), p.237-237, Article 237

2021

Volltextzugriff (PDF)

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Diabetes, obesity & metabolism, 2009-12, Vol.11 (12), p.1163-1172

2009

Volltextzugriff (PDF)

PO47 - Intérêt de l’insuline Degludec, un nouvel analogue ultra-long de l’insuline, en schéma basal-bolus dans le diabète de type 1 : comparaison avec l’insuline Glargine

Diabetes & metabolism, 2011, Vol.37 (1), p.A35-A35

2011

Volltextzugriff (PDF)

Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes

Diabetic medicine, 2015-05, Vol.32 (5), p.618-626

2015

Volltextzugriff (PDF)

Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials

Diabetic medicine, 2013-02, Vol.30 (2), p.226-232

2013

Volltextzugriff (PDF)

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden

Diabetes therapy, 2022-05, Vol.13 (5), p.1125-1129

2022

Volltextzugriff (PDF)

Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes

Current medical research and opinion, 2010-04, Vol.26 (4), p.917-923

2010

Volltextzugriff (PDF)

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

Diabetic medicine, 2006-07, Vol.23 (7), p.729-735

2006

Volltextzugriff (PDF)

A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes

Journal of patient-reported outcomes, 2018-04, Vol.2 (1), p.20-20, Article 20

2018

Volltextzugriff (PDF)

Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

Diabetic medicine, 2012-06, Vol.29 (6), p.716-720

2012

Volltextzugriff (PDF)

Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands

Diabetic medicine, 2012-03, Vol.29 (3), p.303-312

2012

Volltextzugriff (PDF)

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden

Diabetologia, 2020-12, Vol.63 (12), p.2582-2594

2020

Volltextzugriff (PDF)

Resource utilisation and costs for the treatment of diabetes in the developed world: an economical burden that needs to be solved

International journal of clinical practice (Esher), 2009-07, Vol.63 (7), p.980-982

Jendle, J. H.

2009

Volltextzugriff (PDF)

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study

BMJ (Online), 2015-06, Vol.350 (jun22 1), p.h3234-h3234

2015

Volltextzugriff (PDF)

Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results

Journal of medical economics, 2012-10, Vol.15 (s2), p.1-5

2012

Volltextzugriff (PDF)

Carbohydrate Loading Followed by High Carbohydrate Intake During Prolonged Physical Exercise and Its Impact on Glucose Control in Individuals With Diabetes Type 1-An Exploratory Study

Frontiers in endocrinology (Lausanne), 2019-08, Vol.10, p.571-571

2019

Volltextzugriff (PDF)

Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting

International journal of clinical practice (Esher), 2008-06, Vol.62 (6), p.869-876

2008

Volltextzugriff (PDF)

The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study

Neuroscience and biobehavioral reviews, 2023-04, Vol.147, p.105076-105076, Article 105076

2023

Volltextzugriff (PDF)

Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study

Diabetes & metabolism, 2010-04, Vol.36 (2), p.137-143

2010

Volltextzugriff (PDF)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Diabetes & metabolism journal, 2023-09, Vol.47 (5), p.668-681

2023

Volltextzugriff (PDF)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)

Diabetes & metabolism journal, 2023-11, Vol.47 (6), p.882-883

2023

Volltextzugriff (PDF)

Type 1 diabetes: analysis of real-world insulin injection patterns

DIABETOLOGIA, 2020, Vol.63 (Suppl. 1), p.S378

2020

Volltextzugriff (PDF)

Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes

Journal of medical economics, 2012, Vol.15 (2), p.261-263

2012

Volltextzugriff (PDF)

Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden

Diabetes, obesity & metabolism, 2020-09, Vol.22 (9), p.1586-1597

2020

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Humans
(39)
Medicin Och Hälsovetenskap
(38)
Endocrinology & Metabolism
(37)
Diabetes
(23)
Female
(23)
Male
(23)
Adult
(20)
Medical And Health Sciences
(20)
Medicine
(20)
Clinical Medicine
(19)
Insulin
(17)
Klinisk Medicin
(17)
Endocrinology And Diabetes
(16)
Endokrinologi Och Diabetes
(16)
Middle Aged
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Hypoglycemic Agents - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

PO47 - Intérêt de l’insuline Degludec, un nouvel analogue ultra-long de l’insuline, en schéma basal-bolus dans le diabète de type 1 : comparaison avec l’insuline Glargine

Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes

Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden

Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes

Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden

Resource utilisation and costs for the treatment of diabetes in the developed world: an economical burden that needs to be solved

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study

Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results

Carbohydrate Loading Followed by High Carbohydrate Intake During Prolonged Physical Exercise and Its Impact on Glucose Control in Individuals With Diabetes Type 1-An Exploratory Study

Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting

The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study

Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)

Type 1 diabetes: analysis of real-world insulin injection patterns

Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes

Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden

Suchergebnisse filtern